Effects of Atorvastatin on Myonecrosis
Effects of Single-Dose Atorvastatin on Peri-Procedural Myonecrosis During Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes - The NO-MI Study
Sponsor: Beth Israel Deaconess Medical Center
Terminated
slow recruitment
Other terminated trials from Beth Israel Deaconess Medical Center
- Diagnoses Disease · Phase NA · Jun 2025
- Blood Pressure · Jun 2025
- Hidradenitis Suppurativa · Phase PHASE2 · Apr 2025
- Cesarean Section Complications · Phase NA · Feb 2025
- Migraine Headache · Phase NA · Jan 2025
See all terminations from Beth Israel Deaconess Medical Center
Other Coronary Disease trials with similar outcome
This PHASE4 trial investigates Coronary Disease and is currently terminated or withdrawn. Beth Israel Deaconess Medical Center leads this study, which shows 7 recorded versions since 2006 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE4
-
Jan 2018 — Jun 2018 [monthly]
Terminated PHASE4
▶ Show 2 earlier versions
-
Aug 2017 — Jan 2018 [monthly]
Terminated PHASE4
Status: Unknown Status → Terminated · Phase: NA → PHASE4
-
Jan 2017 — Aug 2017 [monthly]
Unknown Status NA
First recorded
May 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Beth Israel Deaconess Medical Center
- Pfizer
For direct contact, visit the study record on ClinicalTrials.gov .